Skip to Content

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

At the 2024 San Antonio Breast Cancer Symposium, Dr. and PhD student Demet Özcan presented a study from the Danish Breast Cancer Study. In this MEDtalk, she presents the study that confirms the prognostic value of tumor-infiltrating lymphocytes (TILs) in breast cancer patients undergoing radiotherapy, validating earlier findings with modern treatment standards.

Demet Özcan

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top